Skip to main content
CivicGate

S 2531
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.

Introduced Jul 30, 2025

Latest action (Mar 19, 2026) Committee on Health, Education, Labor, and Pensions. Hearings held.

Policy area
Issues
Healthcare

Summary

This bill authorizes the Secretary of Health and Human Services to conduct research and award grants to States to increase early detection of and intervention for uterine fibroids. The bill requires HHS to develop evidence-based strategies for early detection that States can implement through grant programs. Grant funds can be used for screening procedures, patient navigation services, awareness campaigns, and improving access to healthcare. The bill also authorizes grants for research on disparities in pain management for uterine fibroid treatment and other intrauterine conditions. The Secretary must report to Congress every two years on the findings and results of the grant programs and research activities.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Actions (3)

  1. Mar 19, 2026 Committee on Health, Education, Labor, and Pensions. Hearings held. · senate
  2. Jul 30, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
  3. Jul 30, 2025 Introduced in Senate

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Committee action

What happened to this bill in committee — the meetings where it was considered and every recorded vote taken on it.

Meetings where this bill was on the agenda

Full text

IN THE SENATE OF THE UNITED STATES

July 30, 2025

Ms. Alsobrooks (for herself and Ms. Lummis) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025”.

SEC. 2. RESEARCH ON UTERINE FIBROID EARLY DETECTION AND INTERVENTION.

(a) In General.—The Secretary of Health and Human Services (referred to in this Act as the “Secretary”) shall—

(1) conduct or support research on increasing early detection of, and intervention for, uterine fibroids; and

(2) based on the results of such research and other relevant information, formulate evidence-based or evidence- informed strategies to increase early detection in health care settings.

(b) Timeline.—The Secretary shall finalize the evidence-based or evidence-informed strategies required by subsection (a)(2) as expeditiously as possible in order to make such strategies available to grantees under section 3 to implement such strategies pursuant to section 3(b)(3).

SEC. 3. GRANTS WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND INTERVENTION.

(a) In General.—The Secretary may award grants to States for carrying out programs—

(1) to increase early detection of, and intervention for, uterine fibroids; and

(2) to develop and implement public awareness and education campaigns for the early detection of, and intervention for, uterine fibroids.

(b) Use of Funds.—A State receiving a grant under this section may use the grant for the following activities, with respect to increasing early detection of, and intervention for, uterine fibroids:

(1) Screening procedures, including advanced gynecological imaging, including payment for such procedures.

(2) Patient navigation services.

(3) Implementation of evidence-based or evidence-informed strategies formulated under section 2(a)(2).

(4) Facilitating access to health care settings.

SEC. 4. RESEARCH WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND INTERVENTION.

The Secretary may award grants to States for the purpose of conducting research, which may include clinical trials, related to—

(1) disparities in pain control and management in uterine fibroid surgical treatment; or

(2) Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions, as the Secretary determines appropriate.

SEC. 5. REPORTS TO CONGRESS.

(a) Reports on Grants.—Not later 2 years after the initial award of grants under section 2 or 3, and every 2 years thereafter, the Secretary shall submit to Congress, and make publicly available on the website of the Department of Health and Human Services—

(1) a report summarizing the findings and results of programs and activities funded through grants awarded under this Act; and

(2) a report outlining research developments and findings related to—

(A) disparities in pain control and management in uterine fibroid surgical treatment; and

(B) Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions, as the Secretary determines appropriate. <all>

Comments

Comments

Loading comments…